Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Antonio Pisani

Showing results (1-10 of 528) with videos related to

Pageof 53
Sort By:
Neurobiology of Disease|February 9, 2011
Towards a new era for dystonia, a high priority for biomedical researchAntonio Pisani
Recenti Progressi in Medicina|October 14, 2021
[The treatment for Fabry disease: focus on agalsidase alpha and beta]Robert Nisticò, Antonio Pisani
Journal of Inherited Metabolic Disease|August 12, 2025
Real-World Migalastat Use in Fabry Disease: Comparative Insights From the Pisani and Hughes StudiesEleonora Riccio, Antonio Pisani
Proceedings of the National Academy of Sciences of the United States of America|March 3, 2009
Levodopa-induced dyskinesia and striatal signaling pathwaysAntonio Pisani, Jie Shen
Giornale Italiano Di Nefrologia : Organo Ufficiale Della Societa Italiana Di Nefrologia|August 8, 2014
[The switch of enzyme therapy in Fabry disease]Eleonora Riccio, Antonio Pisani
Neurobiology of Disease|December 21, 2010
Abnormal plasticity in dystonia: Disruption of synaptic homeostasisAngelo Quartarone, Antonio Pisani
Clinical Kidney Journal|April 11, 2015
Fanconi syndrome with lysinuric protein intoleranceEleonora Riccio, Antonio Pisani
Clinical Genetics|November 14, 2022
New insights in efficacy of different enzyme replacement therapy dosages in Fabry disease: Switch studies data following agalsidase beta shortageEleonora Riccio, Antonio Pisani
Neurobiology of Disease|May 27, 2019
Editorial for neurobiology of disease special issue on dystonia progress in the neurobiology of dystoniaH A Jinnah, Antonio Pisani
Movement Disorders : Official Journal of the Movement Disorder Society|September 23, 2025
Quieting Cholinergic Neurons in DystoniaAntonio Pisani, H A Jinnah
Pageof 53

Showing results (1-10 of 528) with videos related to

Sort By:
Pageof 53
Neurobiology of Disease|February 9, 2011
Towards a new era for dystonia, a high priority for biomedical researchAntonio Pisani
Recenti Progressi in Medicina|October 14, 2021
[The treatment for Fabry disease: focus on agalsidase alpha and beta]Robert Nisticò, Antonio Pisani
Journal of Inherited Metabolic Disease|August 12, 2025
Real-World Migalastat Use in Fabry Disease: Comparative Insights From the Pisani and Hughes StudiesEleonora Riccio, Antonio Pisani
Proceedings of the National Academy of Sciences of the United States of America|March 3, 2009
Levodopa-induced dyskinesia and striatal signaling pathwaysAntonio Pisani, Jie Shen
Giornale Italiano Di Nefrologia : Organo Ufficiale Della Societa Italiana Di Nefrologia|August 8, 2014
[The switch of enzyme therapy in Fabry disease]Eleonora Riccio, Antonio Pisani
Neurobiology of Disease|December 21, 2010
Abnormal plasticity in dystonia: Disruption of synaptic homeostasisAngelo Quartarone, Antonio Pisani
Clinical Kidney Journal|April 11, 2015
Fanconi syndrome with lysinuric protein intoleranceEleonora Riccio, Antonio Pisani
Clinical Genetics|November 14, 2022
New insights in efficacy of different enzyme replacement therapy dosages in Fabry disease: Switch studies data following agalsidase beta shortageEleonora Riccio, Antonio Pisani
Neurobiology of Disease|May 27, 2019
Editorial for neurobiology of disease special issue on dystonia progress in the neurobiology of dystoniaH A Jinnah, Antonio Pisani
Movement Disorders : Official Journal of the Movement Disorder Society|September 23, 2025
Quieting Cholinergic Neurons in DystoniaAntonio Pisani, H A Jinnah
Pageof 53